Senores Pharmaceuticals Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -

1,049.05 +94.25 (9.87%)Updated : 15 May 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Issuance( Retirement)of Debt Net	121.74	59.84	46.59	10.41
Net Changein Cash	97.73	7.05	-3.11	1.58
Cash Taxes Paid	9.17	2.49	1.45	0.14
Net Income/ Starting Line	70.57	24.94	12.44	1.14
Changesin Working Capital	-125.54	-60.67	-15.97	-12.25
Cashfrom Operating Activities	-45.92	-25.70	-1.08	-10.45
Cash Interest Paid	20.36	8.50	1.84	0.51
Cashfrom Financing Activities	573.13	86.98	46.25	36.46
Issuance( Retirement)of Stock Net	15.55	36.99	1.07	4.94
Depreciation/ Depletion	16.84	10.02	1.78	0.71
Other Investing Cash Flow Items Total	-271.96	-2.40	-1.01	-13.76
Capital Expenditures	-157.52	-51.83	-47.28	-10.68
period Type	-	-	-	-
Non- Cash Items	-7.79	-0.07	0.67	-0.04
Financing Cash Flow Items	435.84	-9.85	-1.41	21.11
Deferred Taxes	0.00	0.08	-	-
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-429.48	-54.23	-48.29	-24.44

*All figures in crores except per share values

362.35+23.50(6.94%)

1,122.90+27.30(2.49%)

1,816.90+43.70(2.46%)

1,337.00-24.75 (-1.82%)

4,055.95-74.25 (-1.80%)

Related News